Nervous System News and Research

Latest Nervous System News and Research

Researchers discover that ATP transmits temperature information to afferent sensory neurons

A Japanese research group led by Prof. Makoto Tominaga and Dr. Sravan Mandadi (National Institute for Physiological Sciences: NIPS) found that ATP plays a key role in transmitting temperature information from skin keratinocytes to afferent sensory neurons. Their findings were presented in the Pflugers Archiv European Journal of Physiology published on October 2009.

9 Oct 2009

Bicycling is a way to fight Parkinson's disease for an 81-year old patient

Bob Wilson is not a quitter, and the Parkinson's Center of Oregon at Oregon Health & Science University will benefit from his steely determination October 10 when he and other members of "Team Bob" mount specially constructed bicycles for a fund-raising outing at The Springs at Tanasbourne.

9 Oct 2009

The Quebec Biopharmaceutical Strategy lauded by Sanofi-aventis

Sanofi-aventis Canada welcomes the Quebec Biopharmaceutical Strategy and sees a strong link with its new corporate strategy.

9 Oct 2009

Premature aging of immune system develops amyotrophic lateral sclerosis

Premature aging of the immune system appears to play a role in the development of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to research scientists from the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai Medical Center, the Weizmann Institute of Science in Israel, and Sheba Medical Center in Israel.

9 Oct 2009

American Shared Hospital Services updates on Todd Cancer Institute's proton therapy center development

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today shared a recent announcement regarding progress in the development of a proton therapy center at Todd Cancer Institute at Long Beach Memorial Medical Center.

8 Oct 2009

Omeros announces the pricing of its initial public offering of 6.82 million shares

Omeros Corporation today announced the pricing of its initial public offering of 6.82 million shares of its common stock at a price of $10.00 per share. The underwriters have the option to purchase up to an additional 1.02 million shares to cover over-allotments, if any.

8 Oct 2009

New Leaf Brands' initiative to find cure for MS, will sponsor a participating team for bike ride event

New Leaf Brands, a wholly owned subsidiary of Baywood International, Inc. (OTCBB: BAYW) ("Company"), today announced that the Company will sponsor a participating team in the Multiple Sclerosis/Tappan Zee Bike Ride taking place on Sunday, October 18, 2009 in Tarrytown, New York.

8 Oct 2009

Johns Hopkins researchers identify several genetic links to autism

About 90 percent of autism spectrum disorders have suspected genetic causes but few genes have been identified so far. Now, leading an international team, Johns Hopkins researchers have identified several genetic links to autism, chief among them a variant of semaphorin 5A, whose protein product controls nerve connections in the brain.

8 Oct 2009

Study suggest childhood cancer survivors are less likely to get married

Childhood cancer survivors typically suffer from the long-term effects of cancer treatment on physical health, and results of a new study suggest that social implications also exist, which may affect their chance of an "I do" at the altar.

8 Oct 2009

Zenvia patent application: AVANIR Pharmaceuticals receives USPTO "Notice of Allowance"

AVANIR Pharmaceuticals, Inc. today announced that it has received a “Notice of Allowance” from the United States Patent and Trademark Office (USPTO) announcing that it intends to grant the Company a new patent, extending the period of commercial exclusivity for its lead drug candidate Zenvia™ well into 2025.

8 Oct 2009

Scientists make significant advance towards a solution for neuronal repair

The repair of damaged nerve cells is a major problem in medicine today. A new study by researchers at the Montreal NeurologicaI Institute and Hospital (The Neuro) and McGill University, is a significant advance towards a solution for neuronal repair.

8 Oct 2009

Study reveals large structural differences between natural prions and man-made synthetic analogs

A collaboration between scientists at Vanderbilt University and the University of California, San Francisco has led to the first direct information about the molecular structure of prions. In addition, the study has revealed surprisingly large structural differences between natural prions and the closest synthetic analogs that scientists have created in the lab.

7 Oct 2009

Physical activity during adolescence decreases risk of glioma

While little is known about the causes of glioma, researchers at the National Cancer Institute have found that this rare but often deadly form of brain cancer may be linked to early life physical activity and height.

7 Oct 2009

Research finds 50 million people vaccinated against zoonotic brain infection

Research at the University of Liverpool has supported the vaccination of more than 50 million people against a zoonotic brain infection that affects thousands of children across Asia every year.

7 Oct 2009

Clinical trial of gene transfer therapy for advanced Parkinson's disease

Henry Ford West Bloomfield Hospital is embarking on a research study for advanced Parkinson's disease using a state-of-the-art treatment called gene transfer.

7 Oct 2009

Research to explore diagnosis and treatment of rare diseases

The National Institutes of Health announced today a second phase of the Rare Diseases Clinical Research Network (RDCRN) including funds for 19 research consortia.

7 Oct 2009

Catalyst Pharmaceutical raises $3.97 million from institutional investors

Catalyst Pharmaceutical Partners, Inc. today announced that it has closed its previously announced registered direct offering of 3.97 million shares of its common stock to institutional investors at a price per share of $1.00, representing gross proceeds of $3.97 million.

7 Oct 2009

Biovail provides update on its Phase III program with pimavanserin for Parkinson’s disease psychosis

Biovail Corporation today provided an update on its Phase III program with pimavanserin for Parkinson’s disease psychosis (PDP), which is being pursued in collaboration with ACADIA Pharmaceuticals Inc. Following the announcement on September 1st of disappointing top-line results from the first Phase III PDP trial, Biovail and ACADIA remain committed to the successful development of pimavanserin and have established a development strategy that they believe will strengthen the PDP program.

7 Oct 2009

AVANIR's STAR trial Phase III data to be presented at the World Congress on Controversies in Neurology

AVANIR Pharmaceuticals, Inc. today announced it will present detailed data from the Phase III confirmatory STAR trial in the treatment of pseudobulbar affect (PBA) at the 3rd World Congress on Controversies in Neurology (CONy) in Prague, Czech Republic on October 8 - 11, 2009 and the American Neurological Association (ANA) 134th Annual Meeting in Baltimore, MD on October 11 - 14, 2009.

6 Oct 2009

It is possible to communicate through power of thought alone: Study

New research from the University of Southampton has demonstrated that it is possible for communication from person to person through the power of thought alone.

6 Oct 2009

Nervous System News and Research

Latest Nervous System News and Research

Researchers discover that ATP transmits temperature information to afferent sensory neurons

Bicycling is a way to fight Parkinson's disease for an 81-year old patient

The Quebec Biopharmaceutical Strategy lauded by Sanofi-aventis

Premature aging of immune system develops amyotrophic lateral sclerosis

American Shared Hospital Services updates on Todd Cancer Institute's proton therapy center development

Omeros announces the pricing of its initial public offering of 6.82 million shares

New Leaf Brands' initiative to find cure for MS, will sponsor a participating team for bike ride event

Johns Hopkins researchers identify several genetic links to autism

Study suggest childhood cancer survivors are less likely to get married

Zenvia patent application: AVANIR Pharmaceuticals receives USPTO "Notice of Allowance"

Scientists make significant advance towards a solution for neuronal repair

Study reveals large structural differences between natural prions and man-made synthetic analogs

Physical activity during adolescence decreases risk of glioma

Research finds 50 million people vaccinated against zoonotic brain infection

Clinical trial of gene transfer therapy for advanced Parkinson's disease

Research to explore diagnosis and treatment of rare diseases

Catalyst Pharmaceutical raises $3.97 million from institutional investors

Biovail provides update on its Phase III program with pimavanserin for Parkinson’s disease psychosis

AVANIR's STAR trial Phase III data to be presented at the World Congress on Controversies in Neurology

It is possible to communicate through power of thought alone: Study

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Nervous System News and Research

Latest Nervous System News and Research

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Newsletters you may be interested in